Cancer sites (ICD-9 code) | Zone A (high exposure) | Zone B (medium exposure) | Zone R (low exposure) | ||||||
---|---|---|---|---|---|---|---|---|---|
 | N | RR | 95% CI | N | RR | 95% CI | N | RR | 95% CI |
All cancers (140-208) | 44 | 1.03 | 0.76-1.38 | 270 | 1.00 | 0.89-1.13 | 1808 | 0.96 | 0.91-1.00 |
   Digestive (150-159) | 7 | 0.59 | 0.28-1.23 | 79 | 1.06 | 0.85-1.33 | 495 | 0.94 | 0.85-1.03 |
Esophagus (150) | 0 | - | - | 1 | 0.26 | 0.04-1.91 | 35 | 1.33 | 0.92-1.92 |
Stomach (151) | 3 | 0.86 | 0.28-2.69 | 19 | 0.87 | 0.55-1.37 | 131 | 0.84 | 0.70-1.01 |
Colon (153) | 2 | 0.68 | 0.17-2.72 | 19 | 1.04 | 0.66-1.64 | 137 | 1.04 | 0.87-1.26 |
Rectum (154) | 0 | - | - | 17 | 1.78 | 1.09-2.88 | 71 | 1.05 | 0.82-1.35 |
Liver (155) | 0 | - | - | 14 | 1.29 | 0.76-2.20 | 56 | 0.74 | 0.56-0.97 |
Biliary tract (156) | 0 | - | - | 6 | 2.28 | 1.00-5.17 | 16 | 0.82 | 0.49-1.39 |
Pancreas (157) | 1 | 1.15 | 0.16-8.19 | 3 | 0.56 | 0.18-1.74 | 38 | 0.99 | 0.70-1.40 |
Other digestive (159) | 1 | 6.96 | 0.96-50.6 | 0 | - | - | 3 | 0.46 | 0.14-1.48 |
   Respiratory (160-165) | 7 | 0.88 | 0.42-1.85 | 48 | 0.98 | 0.73-1.30 | 350 | 1.02 | 0.91-1.15 |
Lung (162) | 7 | 1.12 | 0.53-2.36 | 37 | 0.96 | 0.69-1.33 | 280 | 1.04 | 0.92-1.19 |
Pleura (163) | 0 | - | - | 4 | 3.38 | 1.22-9.37 | 5 | 0.60 | 0.24-1.50 |
   Soft tissue sarcoma (171) | 0 | - | - | 0 | - | - | 9 | 1.32 | 0.64-2.73 |
   Soft tissue and visceral sarcomas | 0 | - | - | 3 | 0.82 | 0.26-2.58 | 24 | 0.98 | 0.64-1.51 |
   Melanoma (172) | 1 | 1.62 | 0.23-11.61 | 2 | 0.50 | 0.12-2.03 | 19 | 0.71 | 0.44-1.14 |
Skin (173) | 3 | 1.39 | 0.45-4.32 | 5 | 0.37 | 0.15-0.90 | 88 | 0.93 | 0.75-1.17 |
   Breast (174) | 8 | 1.43 | 0.71-2.87 | 30 | 0.85 | 0.59-1.22 | 249 | 1.00 | 0.88-1.15 |
   Genito-urinary tract (179-189) | 8 | 1.07 | 0.53-2.14 | 46 | 0.98 | 0.73-1.31 | 302 | 0.91 | 0.81-1.03 |
   Uterus (179-182) | 4 | 2.34 | 0.87-6.27 | 10 | 0.93 | 0.49-1.73 | 61 | 0.79 | 0.60-1.03 |
Cervix (180) | 2 | 2.67 | 0.66-10.77 | 7 | 1.47 | 0.69-3.12 | 28 | 0.84 | 0.57-1.25 |
Endometrium (182) | 1 | 1.24 | 0.17-8.82 | 3 | 0.60 | 0.19-1.87 | 27 | 0.73 | 0.49-1.10 |
   Ovary (183) | 1 | 1.11 | 0.16-7.90 | 1 | 0.18 | 0.02-1.25 | 45 | 1.12 | 0.82-1.54 |
   Prostate (185) | 0 | - | - | 7 | 0.94 | 0.45-1.99 | 39 | 0.75 | 0.54-1.05 |
   Testis (186) | 0 | - | - | 2 | 0.82 | 0.20-3.32 | 22 | 1.44 | 0.90-2.31 |
   Bladder (188) | 3 | 1.44 | 0.46-4.49 | 17 | 1.33 | 0.82-2.16 | 84 | 0.94 | 0.75-1.19 |
   Kidney (189) | 0 | - | - | 6 | 0.87 | 0.39-1.96 | 43 | 0.90 | 0.65-1.24 |
   Brain (191) | 2 | 2.43 | 0.60-9.79 | 4 | 0.76 | 0.28-2.045 | 37 | 1.04 | 0.73-1.48 |
Thyroid (193) | 1 | 2.63 | 0.37-18.86 | 4 | 1.60 | 0.59-4.36 | 19 | 1.15 | 0.70-1.89 |
Lymphatic and hematopoietic tissue (200-208) | 4 | 1.39 | 0.52-3.71 | 29 | 1.56 | 1.07-2.27 | 121 | 0.96 | 0.79-1.16 |
   All lymphoma (200-202) | 1 | 0.62 | 0.09-4.41 | 15 | 1.43 | 0.86-2.40 | 72 | 1.02 | 0.80-1.32 |
   Hodgkin's disease (201) | 0 | - | - | 3 | 1.20 | 0.38-3.78 | 23 | 1.46 | 0.91-2.29 |
   Non-Hodgkin's lymphoma (200, 202) | 1 | 0.80 | 0.11-5.69 | 12 | 1.51 | 0.85-2.69 | 49 | 0.90 | 0.66-1.22 |
   Multiple myeloma (203) | 1 | 2.88 | 0.40-20.70 | 6 | 2.77 | 1.2-6.32 | 18 | 1.15 | 0.70-1.91 |
   Leukemia (204-208) | 2 | 2.18 | 0.54-8.76 | 8 | 1.35 | 0.66-2.73 | 31 | 0.77 | 0.53-2.12 |
   Lymphatic leukemia (204) | 1 | 2.78 | 0.39-19.9 | 0 | - | - | 13 | 0.83 | 0.46-1.48 |
   Myeloid leukemia (205) | 1 | 2.23 | 0.31-15.99 | 7 | 2.41 | 1.12-5.18 | 15 | 0.76 | 0.44-1.30 |
   Leukemia, unspecified (208) | 0 | - | - | 1 | 2.16 | 0.29-16.10 | 2 | 0.61 | 0.14-2.60 |